Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia [7]

Leukemia

Volumn 19, Issue 5, 2005, Pages 883-885

  Furtner, M ^a   Straub, R H ^a   Kruger S ^a   Schwarz, H ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ANTIGEN DETECTION; ANTIGEN EXPRESSION; CHRONIC GRANULOCYTIC LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; IMMUNOCYTOMA; LETTER; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SERUM; STATISTICAL PARAMETERS;

EID: 18644383814     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403675     Document Type: Letter

References (8)

1. Michel J, Langstein J, Hofstädter F, Schwarz H. A soluble form of CD137 (ILA/4-1BB) is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. Eur J Immunol 1998; 28: 290-295.
2. Michel J, Schwarz H. Soluble CD137 is selectively expressed by T lymphocytes and correlates with activation induced cell death of lymphocytes. Cytokine 2000; 12: 742-746.
3. DeBenedette MA, Chu NR, Pollok KE, Hurtado J, Wade WF, Kwon BS et al. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J Exp Med 1995; 181: 985-992.
4. Hurtado JC, Kim SH, Pollok KE, Lee ZH, Kwon BS. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28. J Immunol 1995; 155: 3360-3367.
5. Sharief MK. Heightened intrathecal release of soluble CD137 in patients with multiple sclerosis. Eur J Neurol 2002; 9: 49-54.
6. Jung HW, Choi SW, Choi JI, Kwon BS. Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis. Exp Mol Med 2004; 36: 13-22.
7. Martinsson U, Sundstrom C, Glimelius B. Immunophenotype analysis of B-CLL lymphoma and immunocytoma. APMIS 1989; 97: 1025-1032.
8. Stein H. Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells. Immun Infekt 1976; 4: 52-69.